Metraipolis › archive › dc_960cc07ddb05

Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors — Europe PMC PMID:41304857

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41304857
DOI: 10.3390/ph18111608
License (as archived): solo-consultazione
Archived: 2026-11-09T01:49:15.669Z
SHA-256 of the archived text: ec2eb87a7fc45c86e315f79e9073aca2ad199084fe32d133070bb2b6fbd0c698
Stable URL of this page: https://metraipolis.com/documento/dc_960cc07ddb05

How to cite

Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors — Europe PMC PMID:41304857 — Europe PMC (en), https://europepmc.org/article/MED/41304857 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_960cc07ddb05 (Metraipolis archive dc_960cc07ddb05, sha256 ec2eb87a7fc45c86e315f79e9073aca2ad199084fe32d133070bb2b6fbd0c698)

BibTeX

@misc{dc960cc07ddb05,
  title = {Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors — Europe PMC PMID:41304857},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41304857},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_960cc07ddb05; sha256 ec2eb87a7fc45c86e315f79e9073aca2ad199084fe32d133070bb2b6fbd0c698},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304857. Agents can read the archived copy with the MCP tool read_document.